132 related articles for article (PubMed ID: 32040489)
21. Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.
Gupta R; Yan XJ; Barrientos J; Kolitz JE; Allen SL; Rai K; Chiorazzi N; Mongini PKA
J Immunol; 2018 Sep; 201(5):1570-1585. PubMed ID: 30068596
[TBL] [Abstract][Full Text] [Related]
22. Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo.
Purroy N; Abrisqueta P; Carabia J; Carpio C; Palacio C; Bosch F; Crespo M
Oncotarget; 2015 Apr; 6(10):7632-43. PubMed ID: 25544766
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
[TBL] [Abstract][Full Text] [Related]
24. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
26. Culture and Harvest of CpG-Stimulated Peripheral Blood or Bone Marrow in Chronic Lymphocytic Leukemia.
Miller CR; Heerema NA
Methods Mol Biol; 2019; 1881():27-34. PubMed ID: 30350195
[TBL] [Abstract][Full Text] [Related]
27. Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells.
Giebel B; Corbeil D; Beckmann J; Höhn J; Freund D; Giesen K; Fischer J; Kögler G; Wernet P
Blood; 2004 Oct; 104(8):2332-8. PubMed ID: 15231568
[TBL] [Abstract][Full Text] [Related]
28. Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells.
Wu CC; Castro JE; Motta M; Cottam HB; Kyburz D; Kipps TJ; Corr M; Carson DA
Hum Gene Ther; 2003 Jun; 14(9):849-60. PubMed ID: 12828856
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of Proliferation and Migration of Mouse Macrophages by Type B CpG-ODNs Is F-Spondin and IL-1Ra Dependent.
Chen TA; Liao CC; Cheng YC; Chen YP; Hsu YF; Liang CM; Liang SM
PLoS One; 2015; 10(6):e0128926. PubMed ID: 26042735
[TBL] [Abstract][Full Text] [Related]
30. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
[TBL] [Abstract][Full Text] [Related]
31. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
[TBL] [Abstract][Full Text] [Related]
32. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
33. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions.
Lapidot T
Ann N Y Acad Sci; 2001 Jun; 938():83-95. PubMed ID: 11458529
[TBL] [Abstract][Full Text] [Related]
35. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
36. Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro.
Zhu F; McCaw L; Spaner DE; Gorczynski RM
Leuk Res; 2018 Mar; 66():28-38. PubMed ID: 29353760
[TBL] [Abstract][Full Text] [Related]
37. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
38. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
Roda JM; Parihar R; Carson WE
J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
[TBL] [Abstract][Full Text] [Related]
39. [Cytogenetics of chronic lymphocytic leukemia stimulated by CpG-oligodeoxynucleotides and IL-2].
Wang DM; Xu W; Dong HJ; Fang C; Zhu DX; Cao X; Zhu HY; Zhuang Y; Qiu HR; Yang H; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1114-8. PubMed ID: 21129242
[TBL] [Abstract][Full Text] [Related]
40. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
Tarnani M; Laurenti L; Longo PG; Piccirillo N; Gobessi S; Mannocci A; Marietti S; Sica S; Leone G; Efremov DG
Leuk Res; 2010 Sep; 34(9):1189-94. PubMed ID: 20074801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]